Literature DB >> 2788467

Murine thymocytes proliferate in direct response to interleukin-7.

P J Conlon1, P J Morrissey, R P Nordan, K H Grabstein, K S Prickett, S G Reed, R Goodwin, D Cosman, A E Namen.   

Abstract

The ability of interleukin-7 (IL-7) to stimulate murine thymocyte proliferation was investigated. IL-7, either alone or in concert with lectin, induced proliferation of adult thymocytes as well as day 13 fetal and adult CD4-/CD8-thymocytes. The IL-7-induced proliferative response of unfractionated thymocytes could not be inhibited by antibodies to IL-2, or IL-4, IL-6, or the IL-2 receptor. In addition, IL-2, IL-4, and IL-6 were not produced by thymocytes activated with IL-7, as judged by the absence of biologically active cytokine in IL-7-stimulated culture supernatants. IL-7 could act in concert with IL-2 and IL-4 or with IL-4 to enhance the proliferative response of thymocyte cultures. Thus, IL-7 may cause proliferation of thymocytes directly, not indirectly, through production of IL-2, IL-4, or IL-6. IL-7 may then play a significant role in differentiation of T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2788467

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  34 in total

1.  Organization of the murine and human interleukin-7 receptor genes: two mRNAs generated by differential splicing and presence of a type I-interferon-inducible promoter.

Authors:  C M Pleiman; S D Gimpel; L S Park; H Harada; T Taniguchi; S F Ziegler
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

Review 2.  A T cell/B cell/epithelial cell internet for mucosal inflammation and immunity.

Authors:  K Fujihashi; M N Kweon; H Kiyono; J L VanCott; F W van Ginkel; M Yamamoto; J R McGhee
Journal:  Springer Semin Immunopathol       Date:  1997

3.  Autocrine expression of interleukin-7 rescues lymphoid expansion in interleukin-7-deficient mice.

Authors:  B E Rich
Journal:  Immunology       Date:  1997-11       Impact factor: 7.397

4.  Interleukin-7 activates intestinal lymphocytes.

Authors:  M Bilenker; A I Roberts; R E Brolin; E C Ebert
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

5.  IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp).

Authors:  G Ferrari; K King; K Rathbun; C A Place; M V Packard; J A Bartlett; D P Bolognesi; K J Weinhold
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

6.  Stimulation of B-cell lymphopoiesis by interleukin-7 leads to aggravation of murine leishmaniasis.

Authors:  A Gessner; A Will; M Vieth; K Schröppel; M Röllinghoff
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

7.  Antitumor effects of interleukin-7 and adoptive immunotherapy on human colon carcinoma xenografts.

Authors:  W J Murphy; T C Back; K C Conlon; K L Komschlies; J R Ortaldo; T J Sayers; R H Wiltrout; D L Longo
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

8.  Interleukin-7 is a growth factor for Sézary lymphoma cells.

Authors:  A Dalloul; L Laroche; M Bagot; M D Mossalayi; C Fourcade; D J Thacker; D E Hogge; H Merle-Béral; P Debré; C Schmitt
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

9.  The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr.

Authors:  J Drappa; N Brot; K B Elkon
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

10.  Activation of phosphatidylinositol-3 kinase by ligation of the interleukin-7 receptor on human thymocytes.

Authors:  H K Dadi; C M Roifman
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.